» Articles » PMID: 17367521

Transcriptional Profiling of C57 and DBA Strains of Mice in the Absence and Presence of Morphine

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2007 Mar 21
PMID 17367521
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The mouse C57BL/6 (C57) and DBA/2J (DBA) inbred strains differ substantially in many aspects of their response to drugs of abuse. The development of microarray analyses represents a genome-wide method for measuring differences across strains, focusing on expression differences. In the current study, we carried out microarray analysis in C57 and DBA mice in the nucleus accumbens of drug-naïve and morphine-treated animals.

Results: We identified mRNAs with altered expression between the two strains. We validated the mRNA expression changes of several such mRNAs, including Gnb1, which has been observed to be regulated by several drugs of abuse. In addition, we validated alterations in the enzyme activity of one mRNA product, catechol-O-methyltransferase (Comt). Data mining of expression and behavioral data indicates that both Gnb1 and Comt expression correlate with aspects of drug response in C57/DBA recombinant inbred strains. Pathway analysis was carried out to identify pathways showing significant alterations as a result of treatment and/or due to strain differences. These analyses identified axon guidance genes, particularly the semaphorins, as showing altered expression in the presence of morphine, and plasticity genes as showing altered expression across strains. Pathway analysis of genes showing strain by treatment interaction suggest that the phosphatidylinositol signaling pathway may represent an important difference between the strains as related to morphine exposure.

Conclusion: mRNAs with differing expression between the two strains could potentially contribute to strain-specific responses to drugs of abuse. One such mRNA is Comt and we hypothesize that altered expression of Comt may represent a potential mechanism for regulating the effect of, and response to, multiple substances of abuse. Similarly, a role for Gnb1 in responses to multiple drugs of abuse is supported by expression data from our study and from other studies. Finally, the data support a role for semaphorin signaling in morphine effects, and indicate that altered expression of genes involved in phosphatidylinositol signaling and plasticity might also affect the altered drug responses in the two strains.

Citing Articles

Incidence of alternative splicing associated with sex and opioid effects in the axon guidance pathway.

Southey B, Sunderland G, Gomez A, Bhamidi S, Rodriguez-Zas S Gene. 2025; 942:149215.

PMID: 39756548 PMC: 11863264. DOI: 10.1016/j.gene.2025.149215.


Identification of novel genetic loci and candidate genes for progressive ethanol consumption in diversity outbred mice.

Mignogna K, Tatom Z, Macleod L, Sergi Z, Nguyen A, Michenkova M Neuropsychopharmacology. 2024; 49(12):1892-1904.

PMID: 38951586 PMC: 11473901. DOI: 10.1038/s41386-024-01902-6.


Functional genomic mechanisms of opioid action and opioid use disorder: a systematic review of animal models and human studies.

Falconnier C, Caparros-Roissard A, Decraene C, Lutz P Mol Psychiatry. 2023; 28(11):4568-4584.

PMID: 37723284 PMC: 10914629. DOI: 10.1038/s41380-023-02238-1.


Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction.

Kember R, Vickers-Smith R, Xu H, Toikumo S, Niarchou M, Zhou H Nat Neurosci. 2022; 25(10):1279-1287.

PMID: 36171425 PMC: 9682545. DOI: 10.1038/s41593-022-01160-z.


GCSscore: an R package for differential gene expression analysis in Affymetrix/Thermo-Fisher whole transcriptome microarrays.

Harris G, Abbas S, Miles M BMC Genomics. 2021; 22(1):96.

PMID: 33522903 PMC: 7848880. DOI: 10.1186/s12864-021-07370-2.


References
1.
Berrettini W, Ferraro T, Alexander R, Buchberg A, Vogel W . Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat Genet. 1994; 7(1):54-8. DOI: 10.1038/ng0594-54. View

2.
Lessov C, Swan G, Ring H, Khroyan T, Lerman C . Genetics and drug use as a complex phenotype. Subst Use Misuse. 2004; 39(10-12):1515-69. DOI: 10.1081/ja-200033202. View

3.
Hollingshead D, Lewis D, Mirnics K . Platform influence on DNA microarray data in postmortem brain research. Neurobiol Dis. 2005; 18(3):649-55. DOI: 10.1016/j.nbd.2004.10.020. View

4.
McClung C . The molecular mechanisms of morphine addiction. Rev Neurosci. 2006; 17(4):393-402. DOI: 10.1515/revneuro.2006.17.4.393. View

5.
Zhang L, Wang L, Ravindranathan A, Miles M . A new algorithm for analysis of oligonucleotide arrays: application to expression profiling in mouse brain regions. J Mol Biol. 2002; 317(2):225-35. DOI: 10.1006/jmbi.2001.5350. View